GILD w/patent for Tamiflu; only effective drug for new bird flu; about to break-out @ $47 - presentation @ 1:30pm today:
Gilead Sciences to Present at the 2005 UBS Global Life Sciences Conference on Tuesday, September 27th; Webcast Available Through Gilead Corporate Website
FOSTER CITY, Calif., Sep 23, 2005 (BUSINESS WIRE) -- Gilead Sciences, Inc.(Nasdaq: GILD) announced today that it will be webcasting a presentation on thecompany from the 2005 UBS Global Life Sciences Conference in New York, New York.This webcast may be accessed via the company's corporate website atwww.gilead.com.
John F. Milligan, Ph.D., Gilead's Executive Vice President and Chief FinancialOfficer, will provide an overview of the company on Tuesday, September 27th at1:30 p.m. Eastern Time.
To access the live webcast via the internet, log on to www.gilead.com. Pleaseconnect to the company's website at least 15 minutes prior to the livepresentation to ensure adequate time for any software download that may benecessary to listen to the webcast.
Gilead Sciences is a biopharmaceutical company that discovers, develops andcommercializes innovative therapeutics in areas of unmet medical need. Thecompany's mission is to advance the care of patients suffering fromlife-threatening diseases worldwide. Headquartered in Foster City, California,Gilead has operations in North America, Europe and Australia.
For more information on Gilead Sciences, please visit www.gilead.com or call theGilead Public Affairs Department at 1-800-GILEAD-5 (1-800-445-3235). |
